Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (796) Arrow Down
Filter Results: (796) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (796)
    • People  (1)
    • News  (111)
    • Research  (549)
    • Events  (1)
    • Multimedia  (7)
  • Faculty Publications  (317)

Show Results For

  • All HBS Web  (796)
    • People  (1)
    • News  (111)
    • Research  (549)
    • Events  (1)
    • Multimedia  (7)
  • Faculty Publications  (317)
← Page 17 of 796 Results →
  • August 2008 (Revised September 2008)
  • Case

The Flaxil Label (A)

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Disorders; Product Launch; Negotiation Process; Business and Government Relations; Safety; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Barron, Greg M. "The Flaxil Label (A)." Harvard Business School Case 909-001, August 2008. (Revised September 2008.)
  • November 2022
  • Case

Ajax Health: A New Model for Medical Technology Innovation

By: Regina E. Herzlinger and Ben Creo
This case teaches key success factors for both startup and established MedTech firms. It examines how to structure a firm to maximize innovation and financial returns with organizational structures that better align the incentives for the different skill sets... View Details
Keywords: Business Startups; Success; Innovation Strategy; Mergers and Acquisitions; Market Entry and Exit; Financial Strategy; Business Model; Partners and Partnerships; Entrepreneurship; Private Equity; Technology Industry; Medical Devices and Supplies Industry
Citation
Educators
Purchase
Related
Herzlinger, Regina E., and Ben Creo. "Ajax Health: A New Model for Medical Technology Innovation." Harvard Business School Case 323-043, November 2022.
  • May 21, 2020
  • Editorial

Primary Care Is Hurting: Why Aren't Private Insurers Pitching In?

By: Leemore S. Dafny and J. Michael McWilliams
Primary care clinicians are the front line for patients with suspected infection. We rely on them to diagnose, triage, and manage patients with potential or confirmed COVID infections. They are also responsible for keeping non-COVID medical conditions under control... View Details
Keywords: COVID-19; Primary Care; Health Pandemics; Health Care and Treatment; Financial Condition; Insurance
Citation
Read Now
Related
Dafny, Leemore S., and J. Michael McWilliams. "Primary Care Is Hurting: Why Aren't Private Insurers Pitching In?" Health Affairs Blog (May 21, 2020).
  • August 2008 (Revised September 2008)
  • Case

The Flaxil Label (B)

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details
Keywords: Governance; Risk and Uncertainty; Value Creation; Negotiation; Attitudes; Health Care and Treatment; Government Administration; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Barron, Greg M. "The Flaxil Label (B)." Harvard Business School Case 909-002, August 2008. (Revised September 2008.)
  • 24 Jan 2017
  • First Look

First Look at New Research: January 24, 2017

care. The paper contains an interview with Kaplan and Porter about their experiences with improving the measurement of health care outcomes and cost. Publisher's link:... View Details
Keywords: Sean Silverthorne
  • May 2021
  • Article

Choice Architecture in Physician–patient Communication: A Mixed-methods Assessment of Physicians' Competency

By: J. Hart, K. Yadav, S. Szymanski, A. Summer, A. Tannenbaum, J. Zlatev, D. Daniels and S.D. Halpern
Background: Clinicians’ use of choice architecture, or how they present options, systematically influences the choices made by patients and their surrogate decision makers. However, clinicians may incompletely understand this influence.... View Details
Keywords: Choice Architecture; Health Care and Treatment; Interpersonal Communication; Decision Choices and Conditions; Competency and Skills
Citation
Find at Harvard
Related
Hart, J., K. Yadav, S. Szymanski, A. Summer, A. Tannenbaum, J. Zlatev, D. Daniels, and S.D. Halpern. "Choice Architecture in Physician–patient Communication: A Mixed-methods Assessment of Physicians' Competency." BMJ Quality & Safety 30, no. 5 (May 2021).
  • 2009
  • Chapter

Evaluating the Impact of SA8000 Certification

By: Michael J. Hiscox, Claire Schwartz and Michael W. Toffel
SA 8000, along with other types of certification standards and corporate codes of conduct, represents a new form of private governance of working conditions, initiated and implemented by companies, labor unions, and non-governmental activist groups. Whether these codes... View Details
Keywords: Corporate Governance; Working Conditions; Standards; Performance Evaluation
Citation
Read Now
Related
Hiscox, Michael J., Claire Schwartz, and Michael W. Toffel. "Evaluating the Impact of SA8000 Certification." In Social Accountability 8000: The First Decade -- Implementation, Influence, and Impact, edited by Deborah Leipziger. Greenleaf Publishing, 2009.
  • 09 Aug 2016
  • First Look

August 9, 2016

that covers 1992–2008 and many states. We describe differences in the types of businesses initially formed by immigrants and their medium-term growth patterns. We also consider the relationship of these outcomes to the immigrants’ age at... View Details
Keywords: Sean Silverthorne
  • January 2024
  • Article

Cost of Exempting Sole Orphan Drugs from Medicare Negotiation

By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome
Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details
Keywords: Health Care and Treatment; Insurance; Price; Health Industry
Citation
Find at Harvard
Purchase
Related
Vogel, Matthew, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim, and Benjamin N. Rome. "Cost of Exempting Sole Orphan Drugs from Medicare Negotiation." JAMA Internal Medicine 184, no. 1 (January 2024): 63–69.
  • 25 Jan 2024
  • Research & Ideas

Being a Team Player: Why College Athletes Succeed in Business

schools. However, the athletes with the best long-term career outcomes are athletes on teams with slightly lower academic college admission standards, such as football, track, basketball, and hockey, as well as athletes from racially... View Details
Keywords: by Rachel Layne
  • Web

VBHCD Intensive Seminars - Institute For Strategy And Competitiveness

in the book Redefining Health Care, by Michael Porter and Elizabeth Teisberg, value for patients can be assessed by the health outcomes achieved per dollar spent. Value-based... View Details
  • 02 Jul 2013
  • Working Paper Summaries

Religion, Politician Identity, and Development Outcomes: Evidence from India

Keywords: by Sonia Bhalotra, Guilhem Cassan, Irma Clots-Figueras & Lakshmi Iyer
  • 08 May 2018
  • First Look

First Look at New Research and Ideas, May 8, 2018

sourcing decisions. This paper examines how the scheduling of inspections risks introducing bias that erodes inspection quality by altering inspector stringency. In particular, we theorize that inspection results are affected by (a) the inspection View Details
Keywords: Sean Silverthorne
  • 11 Mar 2008
  • First Look

First Look: March 11, 2008

firm's balanced scorecard to provide useful information for detecting problems in its strategy. Download the paper: http://www.hbs.edu/research/pdf/08-081.pdf No Harm, No Foul: The Outcome Bias in Ethical Judgments Authors:Francesca Gino,... View Details
Keywords: Martha Lagace
  • 14 Jul 2015
  • First Look

First Look: July 14, 2015

Case 315-109 Pearson Affordable Learning Fund An in-house venture capital fund for affordable private schools at the base of the pyramid established by Pearson, the world's largest education company, PALF sought to invest in business models providing superior... View Details
Keywords: Sean Silverthorne
  • Program

Finance for Senior Executives

compensation incentives, and play a bigger role in helping your company optimize its financial resources and strengthen its bottom line. Details Apply strategic financial insight Make informed strategic decisions regarding capital structure Utilize capital markets for... View Details
  • October 2003 (Revised January 2005)
  • Case

Shared Decision Making

By: Richard M.J. Bohmer, Karen Sepucha and Laura Feldman
The Foundation for Informed Medical Decision-Making has created an interactive videodisc system that provides patients with customized support regarding medical treatment or screening decisions when they face a choice between two equally effective courses of action.... View Details
Keywords: Decision Choices and Conditions; Borrowing and Debt; Health Care and Treatment; Innovation Strategy; Technological Innovation; Product Marketing; Distribution Channels; Production; Partners and Partnerships; Research and Development; Information Technology
Citation
Educators
Purchase
Related
Bohmer, Richard M.J., Karen Sepucha, and Laura Feldman. "Shared Decision Making." Harvard Business School Case 604-001, October 2003. (Revised January 2005.)
  • Web

Institute For Strategy And Competitiveness

1 | January 2021 To compete successfully in an increasingly value-oriented marketplace, health care providers must adopt a strategic Value Agenda that delivers outcomes that matter to patients through... View Details
  • July 2019 (Revised November 2022)
  • Case

Momofuku Ando and the Globalization of Noodles

By: Geoffrey Jones and Megumi Takada
This case examines the entrepreneurial career of Momofuku Ando, the Taiwanese-born Japanese entrepreneur who pioneered instant boodles with his Chicken Ramen (1958) and Cup Noodle (1971) products. It begins by reviewing his many previous unsuccessful ventures,... View Details
Keywords: Entrepreneurship; Personal Development and Career; Failure; Success; Globalization; Corporate Social Responsibility and Impact; Food and Beverage Industry; Japan
Citation
Educators
Purchase
Related
Jones, Geoffrey, and Megumi Takada. "Momofuku Ando and the Globalization of Noodles." Harvard Business School Case 320-006, July 2019. (Revised November 2022.)
  • Program

Changing the Game

investor, and other important negotiations. Details Achieve optimal results in key negotiations Realize better outcomes by increasing your effectiveness at the negotiating table Build more effective relationships with the other parties... View Details
  • ←
  • 17
  • 18
  • …
  • 39
  • 40
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.